Leap Therapeutics LPTX 深 沪
等待开盘 08-28 09:30:00 美东时间
0.2907
-0.006
-1.89%
华盛通- 最 高0.2999
- 今 开0.2855
- 成交量 33.96万股
- 最 低 0.2855
- 昨 收 0.2963
- 总市值 1204.65万
- 52周最高 4.79
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.2223
- 委 比 71.43%
- 总股本 4143.95万
- 历史最高 153.00
- 量 比 0.25
- 振 幅 4.86%
- 历史最低 0.2223
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
Leap Therapeutics shares are trading lower after the company reported a Q2 EPS miss.
Leap Therapeutics shares are trading lower after the company reported a Q2 EPS ...
08-14 20:35
7月2日十大人气股：好上好人气突破千万
7月2日，沪深两市双双收跌，成交量有所萎缩。板块方面钢铁、光伏设备涨幅居前，元件、通信设备板块跌幅居前。人气股方面亚星锚链收于涨停，安妮股份、长城军工跌幅居前。
07-02 16:03
Leap Therapeutics Reports Updated Results From Part B Of DeFianCe Phase 2 Study Of Sirexatamab In Combination With Bevacizumab And Chemotherapy Vs. Bevacizumab And Chemotherapy For Advanced Microsatellite Stable Colorectal Cancer
Updated data from DeFianCe study continue to demonstrate statistically significant improvements in PFS among the DKK1-high, VEGF-naïve and liver metastasis subgroups
06-23 19:07
Leap Therapeutics Reports Increased Q1 Losses
Leap Therapeutics ( ($LPTX) ) has released its Q1 earnings. Here is a breakdown...
05-28 11:52
Leap Therapeutics GAAP EPS of -$0.37
Leap Therapeutics press release (NASDAQ:LPTX): Q1 GAAP EPS of -$0.37. Cash and cash equivalents totaled $32.7 million at March 31, 2025. More on Leap Therapeutics Leap Therapeutics (LPTX) Conference C...
05-13 19:45
Leap Therapeutics Q1 EPS $(0.37) Beats $(0.38) Estimate
Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.38) by 2.63 percent. This is a 27.45 percent increase over losses of $(0.51) per share from
05-13 19:14
H.C. Wainwright Reaffirms Their Hold Rating on Leap Therapeutics (LPTX)
H.C. Wainwright analyst Swayampakula Ramakanth maintained a Hold rating on Leap...
03-27 18:16
It’s time for investors to rotate, with opportunities down the market cap – Piper Sandler
With the major indices remaining in uptrends despite headline volatility, Craig W. Johnson, chief market technician at Piper Sandler, said investors should continue to see buying opportunities “for do...
02-13 00:09
HC Wainwright & Co. Downgrades Leap Therapeutics to Neutral
HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Leap Therapeutics (NASDAQ:LPTX) from Buy to Neutral.
01-29 19:54
